• Giovana Rosa Gameiro, Gustavo Rosa Gameiro, Renan Magalhães E Silva, GuillouxAline Gil AlvesAGA0000-0002-2760-3720Universidade de São Paulo, Faculty of Medicine, Department of Preventive Medicine - São Paulo (SP), Brazil., Alex Jones Flores Cassenote, and Mario César Scheffer.
• Clínica de Olhos Norte do Paraná - Londrina (PR), Brazil.
• Rev Assoc Med Bras (1992). 2024 Jan 1; 70 (5): e20231317e20231317.

ObjectiveThe objective of this study was to investigate the newly graduated physicians' attitudes and perceptions regarding the medical relationship with the pharmaceutical industry and identify the sociodemographic patterns related to such thinking.MethodsA structured questionnaire was administered to 4,601 participants selected from a pool of 16,323 physicians who were registered with one of the 27 Regional Medical Councils of Brazil in 2015. Answers were analyzed using two stratification variables: type of medical school (public vs. private) and the sex of the respondents.ResultsOut of the participants, 61.8% believed that industry funding could support medical conferences and education, and 48.4% felt that small gifts and conference travel funding were acceptable. Conversely, 64.7% disagreed with industry-sponsored social events. Views on whether pharmaceutical representatives' visits influenced prescriptions were divided. Statistically significant differences were observed between genders and medical school types, with men and private school graduates being more accepting of certain industry interactions.ConclusionThe study highlights the nuanced attitudes of new doctors toward industry relationships, indicating the need for clearer ethical guidelines and education in medical schools to align practice with evolving societal values.

22 keywords...

hide…